Approval · Notice of Compliance 32615 · 2024
NUBAIN: Notice of Compliance 32615
Issued January 29, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32615
- Date
- January 29, 2024
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the inner and outer labels
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NUBAIN | Not yet assigned | — |
Medicinal ingredients
- NALBUPHINE HYDROCHLORIDE 10 MG per ML